Metethoheptazine

From Wikipedia, the free encyclopedia
Jump to navigation Jump to search
Metethoheptazine
Metethoheptazine.svg
Metethoheptazine-3D-balls.png
Clinical data
SynonymsWY-535
ATC code
  • none
Identifiers
CAS Number
PubChem CID
ChemSpider
UNII
Chemical and physical data
FormulaC17H25NO2
Molar mass275.39 g/mol g·mol−1
3D model (JSmol)
 ☒N☑Y (what is this?)  (verify)

Metethoheptazine[1] (WY-535) is an opioid analgesic from the phenazepine family. It was invented in the 1960s.[2]

Metethoheptazine produces similar effects to other opioids, including analgesia, sedation, dizziness and nausea.

Metethoheptazine is not listed as a controlled substance under the Controlled Substances Act 1970 in the United States.[3] The Canadian Controlled Drugs and Substances Act specifically excludes the phenazepine opioids from control.

References[edit]

  1. ^ GB Patent 843924
  2. ^ Walkenstein SS, Corradino RA, Wiser R, Gudmundsen CH. Metabolism of the Non-Narcotic Analgesic, WY-535. Biochemical Pharmacology. 1965 Feb;14:121-8.
  3. ^ "Conversion Factors for Controlled Substances". U.S. Department of Justice Drug Enforcement Administration. Retrieved 8 October 2018.